These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1342899)

  • 21. The inhibitory effect of ketotifen on in vitro histamine release in allergic patients.
    Oehling A; Ona J; Wierna G; Sanz ML; Castillo J
    Allergol Immunopathol (Madr); 1985; 13(6):475-85. PubMed ID: 2421563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of human basophil growth in vitro by xiao-qing-long-tang (syo-seiryu-to), chai-pu-tang (saiboku-to), qing-fei-tang (seihai-to), baicalein and ketotifen.
    Tanno Y; Shindoh Y; Takishima T
    Am J Chin Med; 1989; 17(1-2):45-50. PubMed ID: 2573996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protective effect of ketotifen and disodium cromoglycate in bronchial challenge tests with allergens (author's transl)].
    Klein G; Urbanek R; Matthys H; Hamm M
    Dtsch Med Wochenschr; 1980 Sep; 105(38):1313-5. PubMed ID: 6780292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Furosemide inhibits in vitro histamine release induced by antigens and anti-IgE.
    Croce M; Costa Manso E; Gato JJ; Córdoba H; Oehling A
    J Investig Allergol Clin Immunol; 1992; 2(4):205-10. PubMed ID: 1285275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative evaluation of the effectiveness of sodium cromoglycate and ketotifen in bronchial asthma and their effect on blood histamine and polymyxin-induced bronchial spasm].
    Rozniecki J; Górski P; Szmidt M; Grzelewska-Rzymowska I
    Pneumonol Pol; 1983 Nov; 51(11):547-51. PubMed ID: 6420779
    [No Abstract]   [Full Text] [Related]  

  • 26. A one-year double-blind clinical study of the efficacy and tolerability of picumast dihydrochloride versus ketotifen in patients with bronchial asthma.
    Slapke J; Müller S; Boerner D
    Arzneimittelforschung; 1989 Oct; 39(10A):1368-72. PubMed ID: 2576366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of montelukast on basophil releasability in patients with asthma.
    Sade K; Kivity S; Fireman E; Schwartz Y; Kivity S
    Isr Med Assoc J; 2005 Dec; 7(12):792-5. PubMed ID: 16382702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketotifen in atopic asthma and exercise-induced asthma.
    Petheram IS; Moxham J; Bierman CW; McAllen M; Spiro SG
    Thorax; 1981 Apr; 36(4):308-12. PubMed ID: 6116296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchial asthma induced by mediators produced in vitro by sensitized lymphomonocytes. Protective effect of ketotifen.
    Lech B; Girard JP
    Allergol Immunopathol (Madr); 1987; 15(4):191-4. PubMed ID: 3318348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The orally administered anti-allergic agent, ketotifen; efficacy in atopic and non-atopic bronchial asthma.
    Carrasco E; Galleguillos F; Bernath Z
    Allergol Immunopathol (Madr); 1981; 9(4):335-42. PubMed ID: 7030036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of bronchial hyperreactivity in atopic asthmatics during the period of maximal allergenic risk: a six-month study.
    Dal Negro RW; Turco P; Zoccatelli O; Trevisan F; Pomari C
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):100-3. PubMed ID: 3957492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of the effect of ketotifen on the selective and non-selective histamine release from human basophils].
    Gushchin IS; Zebrev AI
    Biull Eksp Biol Med; 1984 Jan; 97(1):60-3. PubMed ID: 6198010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effects of HC 20-511 (ketotifen) in bronchial asthma and its inhibitory effect on antigen-induced morphological changes of basophils.
    Tanizaki Y; Takahashi K; Goda Y; Sasaki Y; Harada H; Kimura I
    Acta Med Okayama; 1980 Dec; 34(6):383-8. PubMed ID: 6451144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD203c expression on human basophils is associated with asthma exacerbation.
    Ono E; Taniguchi M; Higashi N; Mita H; Kajiwara K; Yamaguchi H; Tatsuno S; Fukutomi Y; Tanimoto H; Sekiya K; Oshikata C; Tsuburai T; Tsurikisawa N; Otomo M; Maeda Y; Hasegawa M; Miyazaki E; Kumamoto T; Akiyama K
    J Allergy Clin Immunol; 2010 Feb; 125(2):483-489.e3. PubMed ID: 20159259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pilot study on basophil activation induced by contrast medium.
    Böhm I; Speck U; Schild HH
    Fundam Clin Pharmacol; 2011 Apr; 25(2):267-76. PubMed ID: 20412314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory cholinergic urticaria successfully treated with ketotifen.
    McClean SP; Arreaza EE; Lett-Brown MA; Grant JA
    J Allergy Clin Immunol; 1989 Apr; 83(4):738-41. PubMed ID: 2651507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of basophils in allergic disease.
    Knol EF; Mul FP; Lie WJ; Verhoeven AJ; Roos D
    Eur Respir J Suppl; 1996 Aug; 22():126s-131s. PubMed ID: 8871057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The basophil histamine release test in the diagnosis of atopic bronchial asthma in children.
    Botuliñska E; Tobolczyk J; Stasiak-Barmuta A; Hofman J
    Inflamm Res; 1999 Apr; 48 Suppl 1():S45-6. PubMed ID: 10350156
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of the new antiallergic drug epinastine and ketotifen on repeated antigen challenge-induced airway hyperresponsiveness in rats.
    Misawa M; Kanai Y; Chiba Y
    Arzneimittelforschung; 1991 Dec; 41(12):1277-80. PubMed ID: 1687721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ketotifen in the oral prophylaxis of bronchial asthma: a review.
    Craps L
    Pharmatherapeutica; 1981; 3(1):18-35. PubMed ID: 6119703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.